Cleveland Clinic “Outsourcing”? 503B Status Would Be Milestone For US FDA’s Compounding Model
Executive Summary
Chronic problem with drug shortages is driving the Cleveland Clinic to consider registering as a 503B “outsourcing” facility. That could be a milestone in FDA’s efforts to encourage the model for high volume compounders.